CDKN2B-AS1 and non-small cell lung carcinoma: A screening of lncRNAs abnormally expressed in plasma of NSCLC patients led to the identification of three lncRNA SPRY4-IT1, ANRIL and NEAT1, all displaying high sensitivity and specificity for NSCLC.